- Home
- ALMS vs AWP Comparison
ALMS vs AWP Comparison
Compare ALMS & AWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMS
- AWP
- Stock Information
- Founded
- ALMS 2021
- AWP 2007
- Country
- ALMS United States
- AWP United States
- Employees
- ALMS N/A
- AWP N/A
- Industry
- ALMS
- AWP Trusts Except Educational Religious and Charitable
- Sector
- ALMS
- AWP Finance
- Exchange
- ALMS NYSE
- AWP Nasdaq
- Market Cap
- ALMS 402.6M
- AWP 352.4M
- IPO Year
- ALMS 2024
- AWP N/A
- Fundamental
- Price
- ALMS $5.00
- AWP $3.78
- Analyst Decision
- ALMS Strong Buy
- AWP
- Analyst Count
- ALMS 7
- AWP 0
- Target Price
- ALMS $28.17
- AWP N/A
- AVG Volume (30 Days)
- ALMS 1.6M
- AWP 331.5K
- Earning Date
- ALMS 05-15-2025
- AWP 01-01-0001
- Dividend Yield
- ALMS N/A
- AWP 12.48%
- EPS Growth
- ALMS N/A
- AWP N/A
- EPS
- ALMS N/A
- AWP N/A
- Revenue
- ALMS N/A
- AWP N/A
- Revenue This Year
- ALMS N/A
- AWP N/A
- Revenue Next Year
- ALMS N/A
- AWP N/A
- P/E Ratio
- ALMS N/A
- AWP N/A
- Revenue Growth
- ALMS N/A
- AWP N/A
- 52 Week Low
- ALMS $3.18
- AWP $3.06
- 52 Week High
- ALMS $13.53
- AWP $4.20
- Technical
- Relative Strength Index (RSI)
- ALMS N/A
- AWP 52.19
- Support Level
- ALMS N/A
- AWP $3.27
- Resistance Level
- ALMS N/A
- AWP $3.59
- Average True Range (ATR)
- ALMS 0.00
- AWP 0.14
- MACD
- ALMS 0.00
- AWP 0.02
- Stochastic Oscillator
- ALMS 0.00
- AWP 79.69
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.
About AWP abrdn Global Premier Properties Fund of Beneficial Interest
Aberdeen Global Premier Properties Fund is a diversified, closed-end management investment company. Its objective is to seek high current income and capital appreciation. It predominantly invests in equity and debt securities of domestic and foreign issuers which are principally engaged in the real estate industry, real estate financing or control real estate assets. Its portfolio of investments consists securities of Industrial REITs, Retail REITs, Data Center REITs, Health Care REITs and others.